/
Surgical Management 2021 ATA® Guidelines for Management of Patients with Anaplastic Surgical Management 2021 ATA® Guidelines for Management of Patients with Anaplastic

Surgical Management 2021 ATA® Guidelines for Management of Patients with Anaplastic - PowerPoint Presentation

TheOneWithNoFilter
TheOneWithNoFilter . @TheOneWithNoFilter
Follow
342 views
Uploaded On 2022-08-04

Surgical Management 2021 ATA® Guidelines for Management of Patients with Anaplastic - PPT Presentation

Surgical evaluation for ATC Immediate airway evaluation Goal R0R1resection Is tumor resectable Determine extent of disease based on rapid and accurate staging Invasion into local structures ID: 935102

surgery evaluation patient invasion evaluation surgery invasion patient atc resection assess surgical airway care tracheostomy required metastases decision anticipated

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Surgical Management 2021 ATA® Guidelin..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Surgical Management

2021 ATA® Guidelines for Management of Patients with Anaplastic Thyroid Cancer

Slide2

Surgical evaluation for ATC

Immediate airway evaluation

Goal: R0/R1resection

Is tumor

resectable

?

Determine extent of disease based on rapid and accurate staging

Invasion into local structures?

Presence of distant metastases?

Is there a role for neoadjuvant therapy?

Goals of Care

Patient centered

Curative vs Palliative

Balance morbidity from surgery with expected benefits

Slide3

Immediate Airway Evaluation

Does the patient have stridor?

Is immediate tracheostomy required to protect airway?

Placement of a tracheostomy results in immediate improvement of upper airway obstruction but requires significant education for care and understanding that tumor location and growth may make management of the tracheotomy complex.

In patients without impending airway compromise, we advise against preemptive tracheostomy placement. (GPS 7)

Slide4

Evaluation of Resectability

Extent of local invasion

High resolution CT scan/MRI neck and chest with contrast to assess for presence of regional disease, vascular or visceral invasion.

Direct laryngoscopy to assess vocal cords, subglottic and upper trachea to assess for function and invasion.

Consider endoscopic evaluation of the esophagus to assess invasion.

Consider

bronchoscopic

evaluation of trachea to assess invasion.

Systemic evaluation

Confirm pathology

Radiological evaluation for distant metastases

Define clinical stage (IVA, IVB, IVC)

Patient comorbidities and fitness for surgery assessed and acceptable.

Patient goals of care, advanced directives defined.

Consensus achieved with patient/family and treatment team for decision for surgery.

Slide5

Surgery for stage IVA/IVB ATC

For patients with

confined (stage IVA/IVB) ATC

in whom R0/R1 resection is anticipated, we

strongly recommend surgical resection

. (R.12)

Radical resection (including laryngectomy, tracheal resections, esophageal resections, and/or major vascular or mediastinal resections) is

generally not recommended given the poor prognosis of ATC

and should be considered only very selectively after thorough discussion by multidisciplinary team, also

considered in light of new information

based upon

mutations present and the availability of targeted therapies

. (R.13)

If surgery is undertaken,

intraoperative frozen section and pathology consultation

may be a helpful adjunct to inform surgical decision making. (GPS 6)

Slide6

Exclusions for Surgery

Patient condition, goals of care or decision making capacity unsuitable for surgery

High volume ATC metastases

Anticipated prohibitive morbidity from required surgical procedure

Unacceptably high risk of extensive laryngeal, tracheal, bilateral recurrent laryngeal nerve, esophageal or vascular resection required for R0/R1 resection

Anticipated post-op recovery prohibitive in context of other needed therapies (chemoradiotherapy)